Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders
Journal of Extracellular Vesicles · 2023-10 · 12 (10)
DOI: 10.1002/jev2.12361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 19.10.2023. Verfasst von Rufan Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, PR China. Hauptthemen laut MEDLINE: Exosomes, Extracellular Vesicles, Autoimmune Diseases, Mesenchymal Stem Cells. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Sun Yat-sen University.
Abstract (Originalsprache)
Existing therapeutics for autoimmune diseases remain problematic due to low efficacy, severe side effects, and difficulties to reach target tissues. Herein, we design multifunctional fusion nanovesicles that can target lesions for the treatment of autoimmune skin diseases. The grapefruit‐derived exosome‐like nanovesicles (GEVs) with anti‐inflammatory and antioxidant effects are first encapsulated with CX5461, an immunosuppressant with anti‐proliferative properties to form GEV@CX5461. In order to enhance therapeutic efficiency and safety, GEV@CX5461 are then fused with CCR6+ nanovesicles derived from membranes of engineered gingiva‐derived mesenchymal stem cells (GMSCs). The resulting FV@CX5461 not only maintain the bioactivity of GEVs, CX5461, and GMSC membranes but also home to inflamed tissues rich in chemokine CCL20 through the chemotaxis function of CCR6 on FVs. Moreover, FV@CX5461 reduce the secretion of inflammatory factors, calm down Th17 cell activation, and induce Treg cell infiltration. Finally, impressive therapeutic efficiency in both psoriasis and atopic dermatitis disease models is demonstrated using FV@CX5461 to reshape the unbalanced immune microenvironment. A nanotherapeutic drug delivery strategy is developed using fusion nanovesicles derived from plant and animal cells with high clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, PR China.
- Department of Oral Surgery, Stomatological Hospital, Southern Medical University, Guangzhou, PR China.
ORCID-Profile: Rufan Huang, Bo Jia, Dandan Su, Manchun Li, Zhanxue Xu, Chao He, Yisheng Huang, Hang Fan, Hongbo Chen, Fang Cheng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Sun Yat-sen University
Zitieren
APA
Huang, R., Jia, B., Su, D., Li, M., Xu, Z., He, C., Huang, Y., Fan, H., Chen, H., & Cheng, F. (2023). Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders. Journal of Extracellular Vesicles, 12(10). https://doi.org/10.1002/jev2.12361
Vancouver
Huang R, Jia B, Su D, Li M, Xu Z, He C, et al. Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders. Journal of Extracellular Vesicles. 2023;12(10). doi:10.1002/jev2.12361
BibTeX
@article{Huang2023,
author = {Huang, Rufan and Jia, Bo and Su, Dandan and Li, Manchun and Xu, Zhanxue and He, Chao and Huang, Yisheng and Fan, Hang and Chen, Hongbo and Cheng, Fang},
title = {Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {10},
doi = {10.1002/jev2.12361}
}
EUVIMED